![Poster: 20 years of Kinase Drug Discovery](https://www.reactionbiology.com/wp-content/uploads/2023/11/Kinase_Poster-Nature2022_thumbnail.png)
![Poster: 20 years of Kinase Drug Discovery](https://www.reactionbiology.com/wp-content/uploads/2023/11/Kinase_Poster-Nature2022_thumbnail.png)
![Comprehensive characterization of CDK inhibitors using a complete panel of all 20 human cyclin-dependent kinases](https://www.reactionbiology.com/wp-content/uploads/2023/11/ReactionBiology_CDK_Poster.png)
Comprehensive characterization of CDK inhibitors using a complete panel of all 20 human cyclin-dependent kinases
![IC50 profiling against 320 protein kinases: Improving the accuracy of kinase inhibitor selectivity testing.](https://www.reactionbiology.com/wp-content/uploads/2023/11/ic50_poster_thumb.png)
IC50 profiling against 320 protein kinases: Improving the accuracy of kinase inhibitor selectivity testing.
![Application of biochemical and cellular activity assays for the characterization of inhibitors targeting disease-relevant mutants of the EGF receptor](https://www.reactionbiology.com/wp-content/uploads/2023/11/EGFR-poster-thumbnail.png)
Application of biochemical and cellular activity assays for the characterization of inhibitors targeting disease-relevant mutants of the EGF receptor
![Characterization of the selective inhibitory effect of KRAS inhibitors in different cellular assay formats](https://www.reactionbiology.com/wp-content/uploads/2023/11/ReactionBiology_Poster_KRAS_Franziska_AACR2023-2.png)